A rare composite lymphoma: follicular and in situ mantle cell.
Haematology Department and Pathology Department, University Hospital Reina Sofía/Instituto Maimonides Investigación, Biomedica (IMIBIC)/University of Córdoba, Córdoba, Spain. p.marijimenez@gmail.com.
Pilar
P
Marí-Jimenez
Haematology Department and Pathology Department, University Hospital Reina Sofía/Instituto Maimonides Investigación, Biomedica (IMIBIC)/University of Córdoba, Córdoba, Spain.
Carmen
C
Martínez-Losada
Haematology Department and Pathology Department, University Hospital Reina Sofía/Instituto Maimonides Investigación, Biomedica (IMIBIC)/University of Córdoba, Córdoba, Spain.
Macarena
M
Centeno-Haro
Haematology Department and Pathology Department, University Hospital Reina Sofía/Instituto Maimonides Investigación, Biomedica (IMIBIC)/University of Córdoba, Córdoba, Spain.
Guillermo
G
Rodríguez-García
Haematology Department and Pathology Department, University Hospital Reina Sofía/Instituto Maimonides Investigación, Biomedica (IMIBIC)/University of Córdoba, Córdoba, Spain.
Carlos
C
Perez-Seoane
Haematology Department and Pathology Department, University Hospital Reina Sofía/Instituto Maimonides Investigación, Biomedica (IMIBIC)/University of Córdoba, Córdoba, Spain.
Joaquín
J
Sánchez-García
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride / Q000008:administration & dosage; D058617:Composite Lymphoma / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008224:Lymphoma, Follicular / Q000175:diagnosis* / Q000188:drug therapy; D020522:Lymphoma, Mantle-Cell / Q000175:diagnosis* / Q000188:drug therapy; D012074:Remission Induction; D000069283:Rituximab / Q000008:administration & dosage; D016896:Treatment Outcome
D000069283:Rituximab; D000069461:Bendamustine Hydrochloride